Dr. Charles Carroll, DO
291 E Layfair DR, Flowood, MS 39232 • +1-508-555-5946
Medical Education: Accredited U.S. Medical School (Class of 2008)
What This Doctor Actually Performs: CMS Medicare Utilization & Flowood Percentiles
NPI #1003846353 • CBSA Regional • Obstetrics & Gynecology
CMS Medicare Part B utilization records credit Dr. Charles Carroll (DO, NPI 1003846353) at 291 E Layfair DR in Flowood with 2,791 annual clinical services (178 beneficiaries), corresponding to a +0.16σ regional deviation and mid-cohort balanced caseload (42.11th Flowood percentile) with sub-specialty concentration in 87 Active CMS HCPCS Codes.
Procedural volume for Dr. Carroll is led by HCPCS 99214 (Gynecologic, Menopause HRT & Endocrine Follow-Up — 597 annual services, $59–$81 GPCI cash estimate), followed by CPT 76830 (Transvaginal Pelvic & Ovarian Diagnostic Ultrasound, 367/yr) and CPT 99213 (Established Women’s Health & Preventive Care Visit, 306/yr).
Self-pay new patient consultations with Dr. Carroll (CPT 99204 GPCI-adjusted benchmark) estimate around $209.00 (community reported average: $209.00) with hybrid in-clinic and telehealth video consults, 18-minute average reception wait, and a 4.78/5 modern protocol openness score across 4 patient logs.
Credentialed as an DO specialist with 18 years post-graduation experience since completing medical school at an LCME/COCA institution (2008), Dr. Carroll coordinates 87 Active CMS HCPCS Codes workups from 291 E Layfair DR (+1-508-555-5946).
Compared against Flowood, MS Obstetrics & Gynecology peers
2,791 annual services across 178 beneficiaries
Standard deviations from MS Obstetrics & Gynecology mean utilization
Top Billed HCPCS/CPT Procedures & GPCI Self-Pay Cash Benchmarks
| HCPCS | Clinical Procedure Description | Annual Volume | Local Pct | Est. Cash Range |
|---|---|---|---|---|
| 99214 | Gynecologic, Menopause HRT & Endocrine Follow-Up | 597 | 42.11th | $59 – $81 |
| 76830 | Transvaginal Pelvic & Ovarian Diagnostic Ultrasound | 367 | 43.11th | $76 – $104 |
| 99213 | Established Women’s Health & Preventive Care Visit | 306 | 47.11th | $46 – $63 |
| 58100 | Endometrial Sampling Biopsy w/ Cannula | 138 | 46.11th | $79 – $109 |
| 99204 | Comprehensive New Patient OB/GYN & Hormone Evaluation | 122 | 47.11th | $83 – $114 |
| 96372 | Therapeutic Subcutaneous/Intramuscular Injection Administration (87 HCPCS billing breadth) | 1,260 | 42.11th | $53 – $77 |
Are you Dr. Charles Carroll? Embed your Official DotMD Verification Badge (0-JS SVG)
Paste this lightweight SVG snippet onto your clinic bio page in Flowood, MS:
<a href="https://dotmd.com/doctors/charles-carroll-do-flowood-ms-1003846353" title="Dr. Charles Carroll, DO - Verified CMS Utilization on DotMD"><img src="https://dotmd.com/badges/npi/1003846353.svg" alt="Dr. Charles Carroll Obstetrics & Gynecology Badge" width="280" height="72" /></a>
Dr. Charles Carroll, DO Fair Cash-Pay & Waiting-Room Scorecard
| Metric | Verified Benchmark | Source |
|---|---|---|
| Dr. Carroll National Provider Identifier | NPI #1003846353 (DO) | CMS NPPES Registry (39232) |
| Dr. Carroll Flowood CMS Volume Rank | 42.11th Pct (2,791 CMS svcs; Z +0.158σ) | CMS Medicare Part B (MS Obstetrics & Gynecology) |
| Fair Cash-Pay New-Patient Benchmark | $209.00 (CPT 99204 GPCI Benchmark) | CMS Geographic Practice Cost Index (Flowood, MS) |
| Waiting-Room Wait Time & Cash Friendliness | $209.00 avg paid • 18 min lobby wait | 4 Anonymous Patient Reports |
| Listens Without Rushing & Modern Protocol Score | 4.91/5 Listening • 4.78/5 Modern Labs | CMS Provider Practice Cohort |
“Waiting Room” Patient Reality Scorecard
Ask our AI Specialists anything about Dr. Charles Carroll
Other High-Volume Obstetrics & Gynecology Specialists in Flowood, MS
Ranked strictly by CMS Medicare volumeDr. Carroll Waiting-Room Q&A & Patient Experience Logs
Anonymous patient-submitted wait times, cash visit fees, and bedside manner discussions in Flowood, MS.
Share your self-pay visit cost and lobby wait time—no account, email, or IP stored.
Filter Dr. Charles Carroll community threads and patient logs by age, biological sex, dosage, and treatment duration.